Journal of the American Psychiatric Nurses Association
August 10, 2023
G. Pearson
The use of psychedelic medications to treat the brain disorders associated with psychiatric illness has re-emerged in recent years as a viable treatment option (Grieco et al., 2022). Historically there is evidence of hallucinogenic use in religious and spiritual rituals dating back to 500 B.C. (Begola & Dowben, 2018). The discovery of LSD (lysergic acid diethylamine-25) in Switzerland in 1943...
Harm Reduction Journal
August 9, 2023
Hagit Bonny-Noach, Barak Shapira, Pinchas Baumol et al.
9 citations
Few studies have analyzed harm reduction behaviors and attitudes among rave party attendees. Since the late 1980s, there has been a large Israeli rave scene, also known as 'Nature Parties'. However, only a few studies have been conducted among nature party attendees and almost all of them are from a qualitative perspective. This study's aim was to fill the gap and conduct quantitative research...
Chemie in Unserer Zeit
August 3, 2023
Frank P. Petersen
Zusammenfassung 1935 isolierten der englische Chemiker Harold Ward Dudley und der schottische Frauenarzt John Chassar Moir das hochpotente, uterotone Ergometrin aus den Sklerotien des Roten Keulenkopfs. Forscherteams in England und den USA zeigten, dass alle damals bekannten Ergotalkaloide einen identischen Baustein besitzen, die Lysergsäure. Die neuen Erkenntnisse motivierten den Schweizer...
ACS Chemical Neuroscience
August 2, 2023
Eline Pottie, Christian B M Poulie, Icaro A Simon et al.
25 citations
Serotonergic psychedelics are described to have activation of the serotonin 2A receptor (5-HT2A) as their main pharmacological action. Despite their relevance, the molecular mechanisms underlying the psychedelic effects induced by certain 5-HT2A agonists remain elusive. One of the proposed hypotheses is the occurrence of biased agonism, defined as the preferential activation of certain...
August 1, 2023
Gabriel Alexandre Moura, ANA Cecilia de Carvalho Cunha, Beatriz Barros Cordeiro et al.
Objetivo: O uso de psicodélicos em psicoterapia tem sido objeto de interesse crescente na última década.Portanto, o objetivo desta revisão sistemática é examinar a literatura científica mais recente sobre os benefícios do uso de psicodélicos na promoção da saúde mental.Metodologia: Os descritores para essa pesquisa foram selecionados pela Descritores em ciência da saúde (DeCS/MeSH), da...
Pharmacology & Therapeutics
August 1, 2023
Ryoichi Fujiwara, Megan Journey, Fatimah Al-Doori et al.
13 citations
Cannabis, cocaine, 3,4-methylenedioxymethamphetamine, and lysergic acid diethylamide are psychoactive substances with a significant increase in consumption during the 21st century due to their popularity in medicinal and recreational use. New psychoactive substances (NPSs) mimic established psychoactive substances. NPSs are known as being natural and safe to consumers; however, they are neither...
Palliative & Supportive Care
August 1, 2023
Xuepeng Jing, Nicholas Hoeh, David B Menkes
18 citations
People with terminal illnesses often experience psychological distress and associated disability. Recent clinical trial evidence has stimulated interest in the therapeutic use of psychedelics at end of life. Much uncertainty remains, however, mainly due to methodological difficulties that beset existing trials. We conducted a scoping review of pipeline clinical trials of psychedelic treatment...
PSYCHOLOGICAL JOURNAL
July 31, 2023
Tetiana Kudrina, Kozlovska Anna
Respondents with experience in the use of psychedelics (psilocybin, LSD, ketamine, MDMA, etc.) participated in the study. Based on the subjective assessment of the level of awareness in the topic of psychedelics, it was found that 49% of respondents have a high level, 47% have an average level, and 4% have a low level of awareness in the topic. Most of the study participants were in Ukraine...
Psychiatric News
July 27, 2023
Terri D’arrigo
1 citation
Back to table of contents Previous article Next article Med CheckFull AccessMed Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and LumryzTerri D’ArrigoTerri D’ArrigoSearch for more papers by this authorPublished Online:27 Jul 2023https://doi.org/10.1176/appi.pn.2023.08.8.3FDA Expedites Review of Anti-Amyloid Beta Vaccine for Alzheimer’s DiseaseThe Food and Drug...
Communications Biology
July 26, 2023
Ivani Brys, Sebastian A Barrientos, Jon Ezra Ward et al.
33 citations
The profound changes in perception and cognition induced by psychedelic drugs are thought to act on several levels, including increased glutamatergic activity, altered functional connectivity and an aberrant increase in high-frequency oscillations. To bridge these different levels of observation, we have here performed large-scale multi-structure recordings in freely behaving rats treated with...